Updated:
Yinfeng Equity
Yinfeng Equity Investment Fund Management(Shanghai) is a private equity firm based in Beijing, China. It focuses on Buyout investments. The firm has a team of...
Yinfeng Equity
Yinfeng Equity Investment Fund Management(Shanghai) is a private equity firm based in Beijing, China. It focuses on Buyout investments. The firm has a team of 10 staff members.
General information
Firm type
Private Equity
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Sector focus
Frequently asked questions
Who controls investment decisions at Yinfeng Equity?
Investment decisions are made by an internal team reporting into Yinfeng Biological Group's leadership. Specific named partners have not been publicly disclosed. The firm's parent, Yinfeng Biological, is a major Chinese healthcare conglomerate whose chairman and senior scientific officers are understood to guide the equity arm's sector appetite.
Does Yinfeng Equity raise third-party capital, or is it a proprietary balance-sheet investor?
Yinfeng Equity invests primarily from the corporate balance sheet of Yinfeng Biological Group. The firm has also brought in select institutional co-investors on larger transactions. It does not publicly market a blind-pool fund to external limited partners in the manner of a traditional private equity firm, making it more akin to a strategic corporate investment platform with a PE mandate.
Does Yinfeng Equity invest outside China?
Primary transaction focus remains mainland China, where the parent's hospital and lab networks provide its strongest sourcing advantage. The firm has evaluated targets in Southeast Asia and North America with the objective of importing technology platforms back into the Chinese market. Cross-border deal volume to date has not been publicly detailed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: